Metabolic Disorders tests in Dubai & UAE

Compare available Metabolic Disorders tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

450.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Metabolic Disorders test prices

Showing 1–15 of 38 matching tests.

Metabolic Disorders diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5963 ACADVL (Very Long-Chain Acyl-CoA Dehydrogenase) Deficiency Genetic Test This test evaluates the ACADVL gene for pathogenic variants associated with Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) deficiency.	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ACADVL gene sequence", "Pathogenic variants in ACADVL gene"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without doctor guidance"] Indications ["Suspected VLCAD deficiency", "Family history of VLCAD deficiency", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 96538-9 ICD-10: E71.310 Clinical summary This test evaluates the ACADVL gene for pathogenic variants associated with Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) deficiency.
TEST-5967 ADSL Gene Adenylosuccinase Deficiency Test This test evaluates the ADSL gene for pathogenic variants associated with Adenylosuccinase Deficiency, a rare inherited metabolic disorder.	Whole Blood (Peripheral)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ADSL gene"] Parameters [] Preparation [] Indications ["Suspected Adenylosuccinase Deficiency", "Family history of the disorder", "Neurological impairment of unknown origin"] Measurement technique Confirm with laboratory Codes LOINC: 94722-6 ICD-10: E79.8 Clinical summary This test evaluates the ADSL gene for pathogenic variants associated with Adenylosuccinase Deficiency, a rare inherited metabolic disorder.
TEST-197 Amino Acids Quantitative Panel (Urine & Plasma, 45 Analytes) Test This test quantifies 45 amino acids in urine and plasma to screen for and diagnose inborn errors of metabolism.	Urine (first morning) + Plasma (sodium heparin)	3 working days from sample receipt (Mon/Wed collection)	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Concentration of 45 amino acids in urine", "Concentration of 45 amino acids in plasma"] Parameters [{"name": "Amino Acids", "reference_range": "Specific reference ranges vary; provided in the report"}] Preparation ["Collect first morning urine in a sterile container without preservatives", "Provide a plasma sample from a sodium heparin green-top tube", "Requires an overnight fast", "Include clinical details and drug history with specimens", "Do not discontinue or alter prescribed medication before consulting physician"] Indications ["Screening for inborn errors of metabolism (IEMs)", "Diagnosis of IEMs like PKU, MSUD, homocystinuria, tyrosinemia, urea cycle disorders", "Metabolic work-up in neonates, children, and adults"] Measurement technique Confirm with laboratory Codes LOINC: 24320-4 ICD-10: Z13.228, R79.8 Clinical summary This test quantifies 45 amino acids in urine and plasma to screen for and diagnose inborn errors of metabolism.
TEST-6008 ARG1 Gene Arginase Deficiency Genetic Test This genetic test identifies pathogenic variants in the ARG1 gene associated with arginase deficiency.	Peripheral whole blood (EDTA or FTA card)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ARG1 gene", "Coverage of coding exons, splice sites, and deep intronic regions"] Parameters [] Preparation ["No specific fasting required", "Inform lab of recent blood transfusions"] Indications ["Suspected arginase deficiency", "Family history of urea cycle disorders", "Neurological symptoms in infants or children"] Measurement technique Confirm with laboratory Codes LOINC: 76527-5 ICD-10: E72.21 Clinical summary This genetic test identifies pathogenic variants in the ARG1 gene associated with arginase deficiency.
TEST-6013 ASL Gene (Argininosuccinic Aciduria) Genetic Test This genetic test identifies pathogenic variants within the ASL gene, confirming or ruling out a diagnosis of Argininosuccinic Aciduria.	Whole Blood (EDTA), Extracted DNA, or FTA Card Dried Blood Spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ASL gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Splice-site mutations"] Parameters [] Preparation ["Pre-test genetic counseling is mandatory", "Detailed pedigree chart of family medical history must be reviewed", "Testing of minors requires informed parental/guardian consent"] Indications ["Clinical symptoms suggestive of Argininosuccinic Aciduria", "Family history of the disease", "Carrier screening", "Pre-conception risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 90237-0 ICD-10: E72.53 Clinical summary This genetic test identifies pathogenic variants within the ASL gene, confirming or ruling out a diagnosis of Argininosuccinic Aciduria.
TEST-6039 BTD Gene (Biotinidase Deficiency) Genetic Test This genetic test evaluates the BTD gene for pathogenic variants associated with biotinidase deficiency.	Whole Blood, Extracted DNA, or FTA Card Blood Spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BTD gene coding region", "Pathogenic variants (SNVs, indels, large rearrangements)"] Parameters [] Preparation ["Prior genetic counselling and clinical history documentation are mandatory", "A pedigree chart must be drawn"] Indications ["Suspected biotinidase deficiency", "Family history of biotinidase deficiency", "Neonates Measurement technique Confirm with laboratory Codes LOINC: 81321-0 ICD-10: E75.22 Clinical summary This genetic test evaluates the BTD gene for pathogenic variants associated with biotinidase deficiency.
TEST-6037 DLD Gene Maple Syrup Urine Disease Type 3 Genetic Test This test evaluates the DLD gene for pathogenic variants associated with Maple Syrup Urine Disease Type 3.	Peripheral Whole Blood (Venous)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DLD gene", "Branched-chain amino acid metabolism disorder"] Parameters [] Preparation [] Indications ["Suspected Maple Syrup Urine Disease Type 3", "Carrier screening for family planning", "Diagnosis in symptomatic individuals"] Measurement technique Confirm with laboratory Codes LOINC: 86900-3 ICD-10: E71.0 Clinical summary This test evaluates the DLD gene for pathogenic variants associated with Maple Syrup Urine Disease Type 3.
TEST-6311 GALK1 Gene Galactokinase Deficiency Genetic Test This genetic test identifies pathogenic variants in the GALK1 gene, confirming galactokinase deficiency (galactosemia type II).	Whole Blood (EDTA tube), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GALK1 gene", "Coding exons and splice junctions of the GALK1 gene", "Copy Number Variations (CNV)"] Parameters [] Preparation ["No special preparation such as fasting is required.", "Continue all prescribed medications unless directed otherwise by your physician."] Indications ["Suspected galactokinase deficiency", "Family history of galactosemia type II", "Screening for carrier status"] Measurement technique Confirm with laboratory Codes LOINC: 82304-8 ICD-10: E74.21 Clinical summary This genetic test identifies pathogenic variants in the GALK1 gene, confirming galactokinase deficiency (galactosemia type II).
TEST-6252 GAMT Gene (Guanidinoacetate Methyltransferase Deficiency) Next‑Generation Sequencing Genetic Test This genetic test evaluates the GAMT gene for mutations causing guanidinoacetate methyltransferase deficiency.	Whole blood (EDTA) or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)", "GAMT gene sequence"] Parameters [] Preparation ["No specific fasting required", "No need to stop prescribed medications unless advised by a physician"] Indications ["Confirmation of suspected guanidinoacetate methyltransferase deficiency", "Carrier screening in families with known GAMT mutations", "Family screening for at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 84591-3 ICD-10: E72.89, Z13.71, Z31.5 Clinical summary This genetic test evaluates the GAMT gene for mutations causing guanidinoacetate methyltransferase deficiency.
TEST-6338 GBE1 Gene Glycogen Storage Disease Type IV Genetic Test This test identifies pathogenic mutations in the GBE1 gene, confirming a diagnosis of Glycogen Storage Disease Type IV (Andersen disease).	Whole blood (EDTA) or FTA card	3-4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GBE1 gene", "Single nucleotide variants", "Small insertions/deletions", "Splice-site mutations"] Parameters [] Preparation ["Mandatory genetic counselling session required.", "No fasting required unless otherwise instructed.", "Continue prescribed medications unless advised otherwise by a doctor.", "Disclose any recent blood transfusions."] Indications ["Suspected Glycogen Storage Disease Type IV (Andersen disease)", "Confirmatory diagnosis", "Family screening for GSD IV", "Early intervention planning", "Proactive management"] Measurement technique Confirm with laboratory Codes LOINC: 50397-9 ICD-10: E74.09 Clinical summary This test identifies pathogenic mutations in the GBE1 gene, confirming a diagnosis of Glycogen Storage Disease Type IV (Andersen disease).
TEST-6356 GK Gene Glycerol Kinase Deficiency Genetic Test This test identifies pathogenic variants in the GK gene, confirming a molecular diagnosis of glycerol kinase deficiency.	Peripheral Whole Blood (3–5 mL EDTA), or Buccal Swab, or FTA Card, or Extracted DNA	3 to 4 Weeks (21–28 days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GK gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations (CNVs)"] Parameters [] Preparation ["Mandatory pre-test genetic counselling session required", "No fasting required", "Consent verification during home visit"] Indications ["Suspected glycerol kinase deficiency", "Family history of glycerol kinase deficiency", "Need for definitive molecular diagnosis", "Guiding family screening and future pregnancies"] Measurement technique Confirm with laboratory Codes LOINC: 81321-1 ICD-10: E74.8 Clinical summary This test identifies pathogenic variants in the GK gene, confirming a molecular diagnosis of glycerol kinase deficiency.
TEST-6256 GLB1 Gene GM1-Gangliosidosis Type 2 Genetic Test This genetic test identifies pathogenic variants in the GLB1 gene associated with GM1-gangliosidosis type 2, a rare autosomal recessive lysosomal storage disorder.	Whole Blood (EDTA, 3–5 mL), Extracted DNA (minimum 2 µg), or FTA Card	3 to 4 Weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GLB1 gene", "Copy Number Variations (CNV) in GLB1"] Parameters [] Preparation ["No fasting required", "Mandatory pre-test genetic counselling session"] Indications ["Suspected GM1-gangliosidosis type 2", "Family history of lysosomal storage disorders", "Carrier status clarification"] Measurement technique Confirm with laboratory Codes LOINC: 101655-8 ICD-10: E75.19, Z14.8, Z13.79 Clinical summary This genetic test identifies pathogenic variants in the GLB1 gene associated with GM1-gangliosidosis type 2, a rare autosomal recessive lysosomal storage disorder.
TEST-6177 GLUD1 Gene Hyperinsulinemic Hypoglycemia Type 6 Genetic Test This genetic test identifies pathogenic variants in the GLUD1 gene associated with congenital hyperinsulinism-hyperammonemia syndrome.	Peripheral Whole Blood	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GLUD1 gene", "Genetic predisposition to hyperinsulinemic hypoglycemia type 6"] Parameters [] Preparation ["No specific fasting required", "Continue all prescribed medications unless advised otherwise by physician"] Indications ["Diagnosis of congenital hyperinsulinism-hyperammonemia syndrome", "Family screening for GLUD1 mutations", "Differentiation of persistent hypoglycemia causes"] Measurement technique Confirm with laboratory Codes LOINC: 82203-5 ICD-10: E16.1 Clinical summary This genetic test identifies pathogenic variants in the GLUD1 gene associated with congenital hyperinsulinism-hyperammonemia syndrome.
TEST-6344 GLUL Gene Glutamine Deficiency, Congenital Test This genetic test identifies mutations in the GLUL gene responsible for congenital glutamine synthetase deficiency.	Peripheral Blood (Whole Blood – EDTA)	15–21 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GLUL gene", "Single-nucleotide variants", "Small insertions/deletions"] Parameters [] Preparation ["No specific fasting required", "Consult physician regarding medication adjustments"] Indications ["Diagnosis of suspected congenital glutamine synthetase deficiency", "Carrier testing in at-risk family members", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 88990-2 ICD-10: E72.24 Clinical summary This genetic test identifies mutations in the GLUL gene responsible for congenital glutamine synthetase deficiency.
TEST-6313 GLYCTK Gene D-Glyceric Aciduria Genetic Test This genetic test analyzes the GLYCTK gene to detect pathogenic variants associated with D-glyceric aciduria.	Peripheral Whole Blood (3–5 mL EDTA) or FTA card (finger-prick dried blood spot)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GLYCTK gene"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication"] Indications ["Suspected D-glyceric aciduria", "Family history of D-glyceric aciduria", "Neurological deterioration in infants/children"] Measurement technique Confirm with laboratory Codes LOINC: 68527-6 ICD-10: E72.8 Clinical summary This genetic test analyzes the GLYCTK gene to detect pathogenic variants associated with D-glyceric aciduria.

Category overview

Metabolic Disorders: overview

Facing complex symptoms like unexplained weight changes or chronic fatigue can be daunting, but targeted diagnostic clarity offers a clear path toward restoring balance. Within our specialized Biochemistry services, advanced testing for Metabolic Disorders deeply evaluates specific enzymatic and hormonal pathways to uncover hidden metabolic dysfunctions. Utilizing cutting-edge diagnostic technology, this comprehensive metabolic disorder screening provides the critical insights necessary to safely guide highly personalized medical treatments, dietary plans, and lifestyle adjustments. Widely respected among premier diagnostic labs in Dubai and the UAE, DNA Labs guarantees strict patient confidentiality, unparalleled diagnostic precision, and rapid, dependable reporting. Reclaim your metabolic health—book your metabolic disorders testing in UAE, schedule a comfortable home sample collection, or connect with our dedicated team of specialists.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.